Rani Therapeutics Holdings Inc at H.C. Wainwright BioConnect Investor Conference Transcript
Hi, everyone, and welcome to the H.C. Wainwright BioConnect conference. My name is Mitchell Kapoor; I'm a Senior Biotechnology Analyst here at H.C. Wainwright. I'm joined today by Talat Imran, the Chief Executive Officer of Rani Therapeutics. It's an exciting time for Rani, and I'm glad you could join us so that we could have a fireside chat. We're just going to have some Q&A back and forth. And hopefully, we'll touch on the main topics that are most important today. So thanks for joining us.
Thank you for having us, Mitchell, and thank you to H.C. Wainwright for making this possible. Really excited to be here.
Questions & Answers
Absolutely. Maybe you could start off by giving us a brief introduction to Rani, where you are today. And then just an overview of the RaniPill in general, there's two generations. So if you could inform the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
